Cite
Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38
MLA
Luciana Chessa, et al. “Activation of NRF2 by Dexamethasone in Ataxia Telangiectasia Cells Involves KEAP1 Inhibition but Not the Inhibition of P38.” PLoS ONE, vol. 14, no. 5, Jan. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9c1d871fd78abc91d54492f0854cbc34&authtype=sso&custid=ns315887.
APA
Luciana Chessa, Mauro Magnani, Luigia Rossi, Sara Biagiotti, & Marzia Bianchi. (2019). Activation of NRF2 by dexamethasone in ataxia telangiectasia cells involves KEAP1 inhibition but not the inhibition of p38. PLoS ONE, 14(5).
Chicago
Luciana Chessa, Mauro Magnani, Luigia Rossi, Sara Biagiotti, and Marzia Bianchi. 2019. “Activation of NRF2 by Dexamethasone in Ataxia Telangiectasia Cells Involves KEAP1 Inhibition but Not the Inhibition of P38.” PLoS ONE 14 (5). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....9c1d871fd78abc91d54492f0854cbc34&authtype=sso&custid=ns315887.